Skip to Main Content

Are prescription drugs like new cars? Is pharma’s grand bargain a sham? And who keeps your DNA safe?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Nicholas Florko joins us for a discussion of the Trump administration’s efforts to get drug prices into TV ads — and the industry’s vehement opposition. And then we talk about why the best-selling drug in the universe is facing competition overseas but retains a monopoly here in the U.S. Kate Black, 23andMe’s chief privacy officer, talks to us about genetic data security in the age of Facebook leaks and cold-case surprises. Finally, we run through a big-money cancer deal, what to expect from Europe’s big oncology meeting, and the legacy of the late Microsoft co-founder Paul Allen.

For more on what we cover, here’s the latest on drug ads; here’s the news on Humira biosimilars; and here’s a transcript of the 23andMe interview.

advertisement

We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on iTunes, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

advertisement


Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].